What makes Tesamorelin different from other GHRH peptides?
Tesamorelin is the only GHRH analog that is FDA-approved for a specific therapeutic use (reducing excess abdominal fat). It uses the full 44 amino acid GHRH sequence with a trans-3-hexenoic acid modification, giving it a longer half-life (~26-38 minutes) than sermorelin and making it particularly effective for reducing visceral (abdominal) fat.
What are the most common side effects?
In clinical trials, the most common side effects included injection site reactions (redness, itching, swelling), joint pain (arthralgia), and peripheral edema (fluid retention in extremities). Some patients also reported muscle pain and paresthesia (tingling sensations). These effects are generally mild and often decrease with continued use.
How effective is Tesamorelin for fat loss?
In FDA clinical trials, Tesamorelin reduced trunk fat by approximately 15-18% over 26 weeks. It specifically targets visceral adipose tissue (VAT) rather than subcutaneous fat, making it particularly effective for reducing dangerous abdominal fat associated with metabolic syndrome and cardiovascular risk.
Does Tesamorelin build muscle?
Yes. Tesamorelin stimulates sustained growth hormone release, which drives protein synthesis and lean muscle accrual. Clinical trials showed significant increases in lean body mass alongside visceral fat reduction — making it one of the few peptides clinically demonstrated to shift body composition in both directions simultaneously. The GH elevation also supports faster workout recovery and connective tissue repair, further supporting muscle-building goals.
Is Tesamorelin FDA-approved?
Yes. Tesamorelin was FDA-approved in November 2010 specifically for the reduction of excess abdominal fat. This makes it unique among GHRH peptides as it has undergone rigorous clinical trials and regulatory review for this specific indication.
What is the typical Tesamorelin dosage?
A common research dosage is 1 mg injected subcutaneously once daily (20 units on 1ml syringe). Best taken AM and/or PM on an empty stomach (2+ hour fast). Protocol: 5 days on, 2 days off, 8 weeks on, 8 weeks off. The FDA-approved dose for lipodystrophy is 2 mg daily.
Why does Tesamorelin target visceral fat specifically?
Growth hormone preferentially mobilizes visceral fat (deep abdominal fat around organs) over subcutaneous fat (fat under the skin). Tesamorelin's ability to increase GH levels results in selective reduction of this metabolically dangerous fat. Visceral fat is linked to insulin resistance, cardiovascular disease, and metabolic syndrome.
Can Tesamorelin be combined with other peptides?
Yes, some combine Tesamorelin with GHRPs like Ipamorelin for enhanced GH release. Others add AOD-9604 for additional fat loss effects. Since Tesamorelin is FDA-approved, it has more established safety data than most peptides, making it a foundation some build upon.
How does Tesamorelin compare to Sermorelin and CJC-1295?
Tesamorelin uses the full 44-amino acid GHRH sequence (vs 29 for Sermorelin), has a longer half-life due to its modification, and is FDA-approved. It's specifically proven for visceral fat reduction. Sermorelin and CJC-1295 are more commonly used for general GH benefits. Tesamorelin is typically more expensive but has stronger clinical validation.
How long does reconstituted peptide last?
Once mixed with bacteriostatic water, peptides remain stable for up to 4 weeks when refrigerated at 2-8°C (36-46°F). Unopened powder can last 1+ year in the freezer. Get our complete Storage & Travel Guide.
Is this peptide legal to purchase?
Peptides sold "for research purposes only" are legal to purchase in the US, but are not FDA-approved for human use outside of specific medical applications. Always consult a healthcare provider before use.
New to peptides?
Take our Peptide Match tool to find the best peptide for your goals. You can also read our Complete Guide to Peptides to learn the basics.